Skip to main content
All lobbying filings

ADVANCED MEDICAL TECHNOLOGY ASSN

Lobbying for ADVANCED MEDICAL TECHNOLOGY ASSN

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $942,000.00 expenses · posted Jan 20, 2026

Official filing document

 Bills named in this filing 8
  • S 1399
    Health Tech Investment Act
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S 2761
    RESULTS Act
  • HR 5269
    RESULTS Act
  • HR 1539
    Medical Device Electronic Labeling Act
  • S 2296
    National Defense Authorization Act for Fiscal Year 2026
  • HR 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
 Lobbying activity 6
Medicare/Medicaid

Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule

Health Issues

Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR) Issues related to National Defense Authorization Act S. 2296/H.R. 3838 Issues related to FDA regulation of diagnostic tests.

Budget/Appropriations

Issues related to appropriations and user fee funding for the Food and Drug Administration

Taxation/Internal Revenue Code

Issues related to R&D Expense Amortization Issues related to small business taxes Issues related to capital investment expensing Issues related to Qualified Small Business Stock

Trade (domestic/foreign)

Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs Japan Reimbursement

Small Business

Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes. Issues related to Qualified Small Business Stock.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem